Abiraterone Acetate, Micronized

Major

Abiraterone Acetate, Micronized Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine exposure and reduced active metabolite (morphine) exposure Details Abiraterone Acetate, Micronized Abametapir Explained Increased exposure of CYP3A4 substrate Details Abiraterone Acetate, Micronized Acarbose Prandase® Explained An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Apixaban Eliquis Explained Increased apixaban exposure Details Abiraterone Acetate, Micronized Aripiprazole Injection Abilify Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate, Micronized Alogliptin Nesina An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Brexpiprazole Rexulti Increased brexpiprazole exposure Details Abiraterone Acetate, Micronized Canagliflozin Invokana An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Dabigatran Pradaxa® Increased dabigatran etexilate exposure Details Abiraterone Acetate, Micronized Dabigatran Etexilate Increased dabigatran etexilate exposure Details Abiraterone Acetate, Micronized Dapagliflozin Farxiga An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Desloratadine Clarinex Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate, Micronized Deutetrabenazine Austedo Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate, Micronized Doxorubicin Adriamycin Increased DOXOrubicin exposure Details Abiraterone Acetate, Micronized Dulaglutide Injection Trulicity An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Edoxaban Savaysa Increased edoxaban exposure Details Abiraterone Acetate, Micronized Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Ertugliflozin Steglatro An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Exenatide Injection Bydureon An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Flecainide Tambocor® Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate, Micronized Glimepiride Amaryl An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Glipizide Glucotrol An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Ifosfamide Injection Ifex Decreased ifosfamide effectiveness Details Abiraterone Acetate, Micronized Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Abiraterone Acetate, Micronized Linagliptin Tradjenta An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Liraglutide Injection Saxenda An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Lixisenatide Injection Adlyxin® An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Loperamide Diamode Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate, Micronized Lurasidone Latuda Increased lurasidone exposure Details Abiraterone Acetate, Micronized Metformin Fortamet® An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Mexiletine Mexitil® Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate, Micronized Miglitol Glyset® An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Montelukast Singulair Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Abiraterone Acetate, Micronized Naloxegol Movantik Increased naloxegol exposure Details Abiraterone Acetate, Micronized Nateglinide Starlix® An increased risk of severe hypoglycemia Details Abiraterone Acetate, Micronized Nebivolol Bystolic Increased CYP2D6 substrate exposure and an increased risk of CYP2D6 substrate-related adverse effects Details Abiraterone Acetate, Micronized Ospemifene Osphena Increased ospemifene exposure and increased risk of adverse events Details